Fig. 1From: Mortality risk after clinical management of recurrent and metastatic adenoid cystic carcinomaKaplan-Meier estimated overall survival, comparing outcomes of recurrent adenoid cystic carcinoma among (a) all patients with low-risk and high-risk recurrence, (b) patients with low-risk and high-risk locoregional recurrence, and (c) patients with low-risk and high-risk distant metastasisBack to article page